- Home
- RXT vs OLMA Comparison
RXT vs OLMA Comparison
Compare RXT & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXT
- OLMA
- Stock Information
- Founded
- RXT 1998
- OLMA 2006
- Country
- RXT United States
- OLMA United States
- Employees
- RXT N/A
- OLMA N/A
- Industry
- RXT EDP Services
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- RXT Technology
- OLMA Health Care
- Exchange
- RXT Nasdaq
- OLMA Nasdaq
- Market Cap
- RXT 509.8M
- OLMA 465.4M
- IPO Year
- RXT 2020
- OLMA 2020
- Fundamental
- Price
- RXT $2.25
- OLMA $6.10
- Analyst Decision
- RXT Hold
- OLMA Strong Buy
- Analyst Count
- RXT 6
- OLMA 5
- Target Price
- RXT $2.47
- OLMA $26.25
- AVG Volume (30 Days)
- RXT 772.4K
- OLMA 1.2M
- Earning Date
- RXT 11-12-2024
- OLMA 11-12-2024
- Dividend Yield
- RXT N/A
- OLMA N/A
- EPS Growth
- RXT N/A
- OLMA N/A
- EPS
- RXT N/A
- OLMA N/A
- Revenue
- RXT $2,771,200,000.00
- OLMA N/A
- Revenue This Year
- RXT N/A
- OLMA N/A
- Revenue Next Year
- RXT N/A
- OLMA N/A
- P/E Ratio
- RXT N/A
- OLMA N/A
- Revenue Growth
- RXT N/A
- OLMA N/A
- 52 Week Low
- RXT $1.45
- OLMA $5.56
- 52 Week High
- RXT $3.41
- OLMA $16.78
- Technical
- Relative Strength Index (RSI)
- RXT 37.73
- OLMA 27.05
- Support Level
- RXT $2.47
- OLMA $5.56
- Resistance Level
- RXT $2.46
- OLMA $6.87
- Average True Range (ATR)
- RXT 0.13
- OLMA 0.81
- MACD
- RXT -0.04
- OLMA -0.28
- Stochastic Oscillator
- RXT 16.98
- OLMA 10.12
About RXT Rackspace Technology Inc.
Rackspace Technology Inc is an end-to-end, hybrid, multi cloud technology services company. It designs, builds and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services; Data; Colocation; Cloud; Managed Hosting; Professional Services; and Security & Compliance. It operates in segments namely, Private Cloud, and Public Cloud. It generates revenue through the sale of consumption-based contracts for its service offerings and from the sale of professional services related to designing and building custom solutions.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.